Immune Checkpoint Blockade Improves Chemotherapy in the PyMT Mammary Carcinoma Mouse Model

Despite the success of immune checkpoint blockade in cancer, the number of patients that benefit from this revolutionary treatment option remains low. Therefore, efforts are being undertaken to sensitize tumors for immune checkpoint blockade, which includes combining immune checkpoint blocking agent...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Front Oncol
Hlavní autoři: Sirait-Fischer, Evelyn, Olesch, Catherine, Fink, Annika F., Berkefeld, Matthias, Huard, Arnaud, Schmid, Tobias, Takeda, Kazuhiko, Brüne, Bernhard, Weigert, Andreas
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2020
Témata:
Oncology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7513675/
https://ncbi.nlm.nih.gov/pubmed/33014872
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.01771
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky